EFFICACY AND SAFETY ASSESSMENT OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO INHALED CORTICOSTEROIDS IN ADOLESCENT PATIENTS WITH SYMPTOMATIC ASTHMA

被引:0
|
作者
Hamelmann, E. [1 ]
Boner, A. [2 ]
Bernstein, J. [3 ]
Moroni-Zentgraf, P. [4 ]
Engel, M. [4 ]
Avis, M. [5 ]
Unseld, A. [6 ]
Vandewalker [7 ]
机构
[1] Ruhr Univ Bochum, Klin Kinder & Jugendmed, Bochum, Germany
[2] Univ Verona, Dept Pediat, I-37100 Verona, Italy
[3] Univ Cincinnati, Cincinnati, OH USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
[5] Boehringer Ingelheim Bv, Alkmaar, Netherlands
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Global Biometr & Clin Applicat, Biberach, Germany
[7] Clin Res Ozarks, Columbia, MO USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
54
引用
收藏
页码:S55 / S55
页数:1
相关论文
共 50 条
  • [1] Safety and tolerability of once-daily tiotropium Respimat® as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis
    Dahl, Ronald
    Engel, Michael
    Dusser, Daniel
    Halpin, David
    Kerstjens, Huib A. M.
    Zaremba-Pechmann, Liliana
    Moroni-Zentgraf, Petra
    Busse, William W.
    Bateman, Eric D.
    RESPIRATORY MEDICINE, 2016, 118 : 102 - 111
  • [2] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO MAINTENANCE THERAPY IN ADOLESCENT PATIENTS WITH SYMPTOMATIC ASTHMA: POOLED SAFETY ANALYSIS
    Mansfield, L.
    Harper, T., III
    Moroni-Zentgraf, P.
    Engel, M.
    Luehmann, R.
    Bernstein, J. A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A55 - A55
  • [3] EFFICACY, SAFETY AND TOLERABILITY OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN CHILDREN WITH MODERATE SYMPTOMATIC ASTHMA
    Schmidt, O.
    Hamelmann, E.
    Vogelberg, C.
    Laki, I.
    El Azzi, G.
    Engel, M.
    Moroni-Zentgraf, P.
    Finnigan, H.
    Vandewalker, M.
    THORAX, 2016, 71 : A167 - A168
  • [5] Safety and tolerability of once-daily tiotropium Respimat® add-on to at least inhaled corticosteroid maintenance therapy in adolescent patients with moderate or severe symptomatic asthma
    Dahl, R.
    Szefler, S. J.
    Bernstein, J.
    Vandewalker, M.
    Engel, M.
    Moroni-Zentgraf, P.
    Unseld, A.
    Hamelmann, E.
    ALLERGY, 2015, 70 : 34 - 35
  • [6] SAFETY AND TOLERABILITY OF ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN CHILDREN WITH SEVERE SYMPTOMATIC ASTHMA
    Hamelmann, E.
    Rupp, N.
    Boner, A.
    El Azzi, G.
    Moroni-Zentgraf, P.
    Engel, M.
    Szefler, S. J.
    PEDIATRIC PULMONOLOGY, 2016, 51 : S61 - S62
  • [7] Safety And Tolerability Of Once-Daily Tiotropium Respimat® Add-On Therapy In Children With Severe Symptomatic Asthma
    Szefler, S. J.
    Rupp, N.
    Boner, A.
    El Azzi, G.
    Moroni-Zentgraf, P.
    Engel, M.
    Hamelmann, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [8] Once-daily tiotropium respimat add-on to at least ICS in adult patients with symptomatic asthma: Pooled safety analysis
    Dusser, Daniel
    Buhl, Roland
    Castro, Mario
    Kerstjens, Huib
    Paggiaro, Pierluigi
    Engel, Michael
    Moroni-Zentgraf, Petra
    Unseld, Anna
    Bateman, Eric
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [9] ONCE-DAILY TIOTROPIUM RESPIMAT ADD-ON TO AT LEAST ICS IN ADULT PATIENTS WITH SYMPTOMATIC ASTHMA: POOLED SAFETY ANALYSIS
    Frith, P.
    Dusser, D.
    Buhl, R.
    Castro, M.
    Kerstjens, H.
    Paggiaro, P.
    Engel, M.
    Moroni-Zentgraf, P.
    Unseld, A.
    Bateman, E.
    RESPIROLOGY, 2015, 20 : 137 - 137
  • [10] Once-Daily Tiotropium Respimat Add-on to Inhaled Corticosteroids Over 1 Year Improves Lung Function in Adolescent Patients With Moderate Symptomatic Asthma, Independent of Patients Baseline Characteristics
    Vandewalker, Mark
    Harper, Thomas
    Moroni-Zentgraf, Petra
    Engel, Michael
    Luehmann, Reinhold
    Bernstein, Jonathan
    CHEST, 2015, 148 (04)